TWMP
GBT

Taylor Wealth Management Partners’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Taylor Wealth Management Partners’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$892K Sell
27,917
-1,698
-6% -$49.7K 0.51% 40
2022
Q1 		$1.03M Sell
29,615
-572
-2% -$17.1K 0.42% 46
2021
Q4 		$884K Sell
30,187
-33,864
-53% -$1.05M 0.31% 44
2021
Q3 		$1.63M Sell
64,051
-6,519
-9% -$192K 0.58% 47
2021
Q2 		$2.47M Sell
70,570
-67
-0.1% -$2.62K 0.87% 39
2021
Q1 		$2.88M Buy
70,637
+6,316
+10% +$290K 1.05% 38
2020
Q4 		$2.79M Buy
64,321
+11,724
+22% +$578K 1.07% 36
2020
Q3 		$2.9M Buy
52,597
+9,680
+23% +$615K 1.33% 30
2020
Q2 		$2.71M Sell
42,917
-2,188
-5% -$150K 1.38% 28
2020
Q1 		$2.3M Sell
45,105
-411
-0.9% -$27.5K 1.41% 26
2019
Q4 		$3.62M Sell
45,516
-210
-0.5% -$12.4K 1.67% 22
2019
Q3 		$2.22M Buy
45,726
+925
+2% +$48.2K 1.04% 27
2019
Q2 		$2.36M Buy
44,801
+217
+0.5% +$12.5K 1.1% 26
2019
Q1 		$2.36M Sell
44,584
-204
-0.5% -$10K 1.17% 26
2018
Q4 		$1.84M Buy
44,788
+2,605
+6% +$97.6K 1.06% 26
2018
Q3 		$1.6M Buy
42,183
+1,642
+4% +$72.7K 0.68% 36
2018
Q2 		$1.83M Sell
40,541
-275
-0.7% -$12.5K 0.81% 36
2018
Q1 		$1.97M Sell
40,816
-8,049
-16% -$449K 0.95% 35
2017
Q4 		$1.92M Buy
48,865
+1,300
+3% +$48.6K 0.82% 38
2017
Q3 		$1.48M Buy
+47,565
New +$1.34M 0.66% 40

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Taylor Wealth Management Partners's GBT Position: Q2 2022 in Review

Taylor Wealth Management Partners reduced its Global Blood Therapeutics, Inc. (GBT) stake by 5.7% in Q2 2022, selling an estimated $49.7K and leaving 27,917 shares worth $892K. The position accounts for 0.51% of the portfolio, ranked #40.

Taylor Wealth Management Partners first reported a position in GBT in Q3 2017 and has held it in 20 quarters since. The position peaked at $3.62M in Q4 2019. 195 funds tracked by Wall St. Rank hold GBT as of Q2 2022.

  • Taylor Wealth Management Partners held 27,917 shares of Global Blood Therapeutics, Inc. worth $892K as of Q2 2022.
  • Taylor Wealth Management Partners sold 1,698 Global Blood Therapeutics, Inc. shares in Q2 2022, an estimated $49.7K.
  • Global Blood Therapeutics, Inc. made up 0.51% of Taylor Wealth Management Partners's portfolio in Q2 2022, its #40 holding.
  • Taylor Wealth Management Partners first reported a position in Global Blood Therapeutics, Inc. in Q3 2017 and has held it in 20 quarters since.
  • Taylor Wealth Management Partners's Global Blood Therapeutics, Inc. position peaked at $3.62M in Q4 2019.
  • 195 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2022.

Based on Taylor Wealth Management Partners's 13F filing for Q2 2022, filed 12 Aug 2022.